NexGard

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2014-2016
012320142016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The Australian paralysis tick, Ixodes holocyclus, causes paralysis predominantly in dogs and cats in the Eastern coastal regions… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2017
2017
Despite large-scale reductions in Chagas disease prevalence across Central and South America, Trypanosoma cruzi infection remains… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2016
2016
The acaricidal efficacy of afoxolaner (NexGard(®), Merial) was evaluated against Sarcoptes scabiei var. canis in a field efficacy… (More)
  • table 2
  • table 1
  • table 3
  • table 4
  • table 5
Is this relevant?
2016
2016
The efficacy of a single 2.5 mg/kg dose of afoxolaner (NexGard®, Merial) against induced Otodectes cynotis infestations was… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2016
2016
A randomized, blinded, negative controlled study was conducted to determine whether treatment with afoxolaner (NexGard®, Merial… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2015
2015
A study was designed to compare the efficacy of NexGard(®) and Bravecto™, 2 recently introduced oral ectoparasiticides containing… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
2014
2014
The speed of efficacy of afoxolaner (NexGard) against Ctenocephalides felis fleas was evaluated in two studies. Study A assessed… (More)
  • table 1
  • table 2
Is this relevant?